Get startedLog in
    Picture of Cosmo First logo

    COSMOFIRST — Cosmo First News Story

    0.000.00%
    in flag iconLast trade - 00:00
    Basic MaterialsSpeculativeSmall CapNeutral
    All News

    Brief: Cosmo: successful outcome of phase III clinical trial for Rifamycin SV MMX

    Picture of Cosmo First logoCosmo First
    06/06/2016 06:01
    June 6 (Reuters) - Cosmo Pharmaceuticals SA  COPN.S : 
    * Cosmo announces successful outcome of phase III clinical trial for Rifamycin SV MMX 
 
Source text for Eikon:  ID:nTEN9s84ra  
Further company coverage:  COPN.S  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on Cosmo First

    See all news